Live Breaking News & Updates on Ncannex Healthcare Kurs

Stay updated with breaking news from Ncannex healthcare kurs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

17.01.2024 - MELBOURNE, Australia and NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) - Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine . Seite 1 ....

Airway Pressure , Positive Airway , Incannex Healthcare Chart , Ncannex Healthcare Kurs , Incannex Healthcare Aktie ,